Company news
bioAffinity Technologies, Inc. news in 2022
bioAffinity Technologies, Inc.'s news releases, calls and decks from 2022, newest first.
bioAffinity Technologies Expands Diagnostic Division with Promotions and New Hires to Strengthen Clinical Bench
December 14, 2022
bioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB-EMBO Meeting
November 30, 2022
bioAffinity Technologies Reports Third Quarter 2022 Financial Results and Provides Business Update
November 13, 2022
bioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company’s Scientific and Medical Advisory Board
November 9, 2022
bioAffinity Technologies to Report Third Quarter 2022 Financial Results
November 7, 2022
bioAffinity Technologies Announces Award of Therapeutic Patents in China, Mexico and Australia
October 24, 2022
bioAffinity Technologies Receives Additional $7.7M from Exercise of Warrants, Total Capital from Public Offering Increases to Approximately $15.6M
September 27, 2022
bioAffinity Technologies, Inc. Announces Closing of $7.8 Million Initial Public Offering
September 5, 2022
bioAffinity Technologies Announces Pricing of IPO
August 31, 2022